TABLE 3.
Clinical information of patients with tic disorder (TD) and healthy controls (HCs).a
| No. | Study | Diagnoses (n) | Diagnostic instrument | Disease duration (SD), year | YGTSS scores (SD) | Comorbidities (n) | GSI (SD) | Gastrointestinal disturbances (%) | Medication (n) |
| 1 | Lee and Wong (2018) | TS: severe tics (14); mild tics (10) | N/A | severe tics: 4.5 (2.33) mild tics: 2.25 (2.5) | TTS scores: severe tics, 27.4 (7.5); mild tics, 14.8 (4.1) | N/A | N/A | N/A | N/A |
| 2 | Zhao et al. (2020) | TS | DSM-5 | 1.5–4 | YGTSS-TTS > 13 | ADHD (3), variant asthma (1) | N/A | N/A | Tiapride (3); aripiprazole (2); trihexyphenidyl (2); risperidone (1) |
| 3 | Xi et al. (2021) | TD: TS (23); PTD (17); CTD (9) | DSM-5 | 2.11 (1.92) | 36.71 (16.73) | N/A | 2.31 (1.86) | mild constipation, 26.53; abdominal pain, 28.57 | DRAs (12); topiramate (1); valproate (1); treatment-naive (35) |
aSD, standard deviation; YGTSS, Yale Global Tic Severity Scale; YGTSS-TTS, Yale Global Tic Severity Scale Total Tic Scale (combined motor tic and vocal tic score); GSI, Gastrointestinal Severity Index; TD, tic disorder; PTD, provisional tic disorder; CTD, chronic motor or vocal tic disorder; TS, Tourette syndrome; DRA, dopamine receptor antagonist.